subject: CHEBI:75998


subject: CHEBI:75998

subject_name: Trametinib

object_name: stage IIA pancreatic cancer

tested_intervention: unsure


subject: CHEBI:75998

object_name: Pancreatic carcinoma stage III


subject: CHEBI:75998

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:75998

object_name: stage IIB pancreatic cancer


subject: CHEBI:75998

object_name: Stage IIB Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:75998

object_name: Stage IIB Pancreatic Cancer AJCC v8


subject: CHEBI:75998

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: complications of organ transplant stem cells

tested_intervention: yes


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18

object_name: acute myeloid leukemia by FAB classification


subject: UNII:2X1K91UT6N

object_name: acute myeloid leukemia


subject: UNII:2X1K91UT6N

object_name: acute lymphoblastic leukemia


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Rotator Cuff Injuries


subject: CHEBI:60648

object_name: Rotator Cuff Injury, CTCAE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:31355

subject_name: Carboplatin

object_name: malignant neoplasm of cervix TNM staging regional lymph nodes (N)


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: acute graft versus host disease


subject: UMLS:C0042210

subject_name: Vaccines

object_name: renal carcinoma


subject: UMLS:C0042210

object_name: kidney neoplasm


subject: UMLS:C0042210

object_name: kidney cancer


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C0010347

subject_name: cromoglycate

object_name: mastocytosis


subject: CHEBI:59773

subject_name: CROMOLYN


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Acute myeloid leukemia with 11q23-abnormality in relapse


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:45716

subject_name: Vorinostat


subject: UNII:67RM91WDHQ

subject_name: Onvansertib


subject: UNII:67RM91WDHQ


subject: CHEBI:6402

subject_name: Leflunomide

object_name: Viruria


subject: CHEBI:6402

object_name: Viremia


subject: CHEBI:6402

object_name: Viremia, CTCAE


subject: CHEBI:16742

subject_name: Orotic acid


subject: CHEBI:16742


subject: CHEBI:16742


subject: CHEBI:131174

subject_name: Navitoclax

object_name: leukemia


subject: UMLS:C1831992

subject_name: ABT 263


subject: UMLS:C0700607

subject_name: digoxin antibodies Fab fragments

object_name: acute kidney failure


subject: UMLS:C0700607

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:75317

object_name: genetic disease


subject: CHEBI:75317

object_name: intrahepatic cholestasis


subject: CHEBI:41500

subject_name: Phenylbutyrates


subject: CHEBI:41500


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: graft versus host disease


subject: PUBCHEM.COMPOUND:135402009

object_name: mucositis


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: UMLS:C4329282

subject_name: Albumin-binding Cisplatin Prodrug BTP-114

object_name: pancreatic neoplasm


subject: UMLS:C4329282

object_name: prostate cancer


subject: UMLS:C4329282

object_name: prostate neoplasm


subject: UMLS:C4329282

object_name: ovarian cancer


subject: UMLS:C4329282

object_name: ovarian neoplasm


subject: UMLS:C4329282

object_name: breast neoplasm


subject: CHEBI:66910

subject_name: Axitinib

object_name: Plexosarcoma


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: gastric cancer


subject: UMLS:C4331433

subject_name: Truncated Tissue Factor/NGR Peptide

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4331433

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4331433

object_name: sarcoma


subject: UMLS:C4331433

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4331433

object_name: soft tissue sarcoma


subject: PUBCHEM.COMPOUND:91668172

subject_name: acyl-ghrelin

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:91668172

object_name: Diabetes


subject: PUBCHEM.COMPOUND:91668172

object_name: diabetes mellitus


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Breast Cancer Lymphedema


subject: CHEBI:3756

subject_name: Clonazepam

object_name: post-traumatic stress disorder


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:85990

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:85990

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:85990

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:85990

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:85990

object_name: Rectal cancer stage IV


subject: CHEBI:85990

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:85990

object_name: Recurrent Rectal Cancer


subject: CHEBI:85990

object_name: Colon cancer recurrent


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: discoid lupus erythematosus


subject: UMLS:C1831854

subject_name: catumaxomab

object_name: fallopian tube neoplasm


subject: UMLS:C1831854

object_name: peritoneal neoplasm


subject: UNII:RD4ZKJ67G3

object_name: Embolism, Tumor


subject: UNII:RD4ZKJ67G3

object_name: Neoplasm Metastasis


subject: UNII:RD4ZKJ67G3

object_name: Metastasis


subject: UNII:RD4ZKJ67G3

object_name: Metastatic Lesion


subject: UNII:RD4ZKJ67G3

object_name: neoplasm


subject: UNII:RD4ZKJ67G3

object_name: Tumor Mass


subject: CHEBI:51041

subject_name: Acamprosate

object_name: Complication of transplanted liver


subject: UMLS:C2697920

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL2107867

subject_name: CENPLACEL-L

object_name: Stage 2 pulmonary sarcoidosis


subject: CHEMBL.COMPOUND:CHEMBL2107867

object_name: Stage 3 pulmonary sarcoidosis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: hemophilia A


subject: GTOPDB:8414

subject_name: trebananib

object_name: Adult Angiosarcoma


subject: GTOPDB:8414

object_name: stage III adult soft tissue sarcoma


subject: GTOPDB:8414

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: GTOPDB:8414

object_name: Stage IV adult soft tissue sarcoma


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UMLS:C1541521

subject_name: AMG 386


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: ENSAT Stage III Adrenal Cortical Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ENSAT Stage II Adrenal Cortical Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: ENSAT Stage I Adrenal Cortical Carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:6954

subject_name: Mitotane


subject: CHEBI:6954


subject: CHEBI:6954


subject: UNII:SCJ765569P

subject_name: HOLY BASIL LEAF

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:SCJ765569P

object_name: obesity


subject: UNII:SCJ765569P

object_name: Obesity, CTCAE


subject: MESH:D002214

subject_name: Capsules


subject: MESH:D002214


subject: MESH:D002214


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: Varicose Ulcer


subject: CHEBI:46859

subject_name: Polidocanol


subject: PUBCHEM.COMPOUND:11397705

subject_name: Pemafibrate

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:11397705

object_name: Dyslipidemia


subject: CHEBI:7820

subject_name: Oxandrolone

object_name: decubitus ulcer


subject: PUBCHEM.COMPOUND:9886134

subject_name: Branched chain amino acids

object_name: concussion


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: colorectal cancer


subject: CHEBI:184023

object_name: colorectal carcinoma


subject: CHEBI:184023

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: PR:000004321


subject: CHEBI:135752

subject_name: Tafenoquine

object_name: babesiosis


subject: CHEBI:25805

subject_name: oxygen atom

object_name: post operative nausea and vomiting


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:6015

subject_name: Isoflurane

object_name: treatment resistant depression


subject: CHEBI:6015


subject: CHEBI:6015

object_name: Depressed mood


subject: CHEBI:6015

object_name: major depressive disorder


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:125354

subject_name: Plerixafor

object_name: lymphoproliferative syndrome


subject: CHEBI:125354

object_name: plasma cell neoplasm


subject: CHEBI:95165

object_name: childhood malignant neoplasm


subject: CHEBI:95165

object_name: Malignant obstetric neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: diffuse midline glioma


subject: UMLS:C3827072


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: mast cell leukemia


subject: UNII:QQA9MLH692

object_name: Multiple cutaneous leiomyomas


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:9831414

object_name: obesity


subject: PUBCHEM.COMPOUND:9831414

object_name: Obesity, CTCAE


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: UNII:79R3ZF226Y

object_name: dental caries


subject: UNII:79R3ZF226Y

object_name: Dental Caries, CTCAE


subject: CHEBI:53228


subject: CHEBI:53228


subject: CHEBI:60622


subject: CHEBI:60622


subject: CHEBI:87647

subject_name: tolonium chloride


subject: CHEBI:87647


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: Head and neck cancer metastatic


subject: UMLS:C3898587

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Complications of Diabetes Mellitus


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Postoperative Pain, Chronic


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: congenital heart disease


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEBI:78538

object_name: cardiomyopathy


subject: CHEBI:3175

subject_name: Brimonidine


subject: PUBCHEM.COMPOUND:3367

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:135565609

subject_name: Hetrombopag olamine

object_name: Chemotherapy-Induced Thrombocytopenia


subject: UMLS:C5418132

subject_name: Hetrombopag Olamine


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Adverse drug response


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: UMLS:C0077906


subject: UNII:6V5T4O5758

object_name: Solid Neoplasm


subject: CHEBI:92795

object_name: prostate carcinoma


subject: CHEBI:92795

object_name: prostate cancer


subject: CHEBI:37628

subject_name: desmosine


subject: CHEBI:37628


subject: CHEBI:34699

subject_name: diethyl sulfate


subject: CHEBI:34699


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN


subject: PUBCHEM.COMPOUND:21628493


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: lip and oral cavity squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Laryngeal Spindle Cell Squamous Carcinoma


subject: PUBCHEM.COMPOUND:138567123

subject_name: Baloxavir

object_name: Influenza-like illness


subject: PUBCHEM.COMPOUND:138567123

object_name: Flu-Like Symptoms


subject: UNII:W530IRZ40G

object_name: coronary artery disorder


subject: UNII:W530IRZ40G

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:11422859

object_name: Treatment related acute myeloid leukaemia


subject: CHEMBL.COMPOUND:CHEMBL5314984

subject_name: GENTULIZUMAB

object_name: lymphoma, non-Hodgkin, familial


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: non-Hodgkin lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314984

object_name: Solid Neoplasm


subject: UMLS:C5853526

subject_name: Gentulizumab


subject: UMLS:C5853526


subject: UMLS:C5853526


subject: UMLS:C5853526


subject: UMLS:C5853526


subject: UMLS:C5853526


subject: UMLS:C5853526


subject: UMLS:C4287778

subject_name: Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601

object_name: metastatic prostate carcinoma


subject: UMLS:C4287778

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: Chronic Kidney Disease, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C1655338

subject_name: Vitamine

object_name: chronic kidney disease


subject: UMLS:C1655338


subject: CHEBI:3655

subject_name: Chlorzoxazone

object_name: osteoarthritis, hip


subject: CHEBI:3655

object_name: osteoarthritis susceptibility 5


subject: CHEBI:3655

object_name: osteoarthritis, knee


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: pancreatic neuroendocrine tumor


subject: UNII:2CN60TN6ZS

object_name: Neuroendocrine tumor of pancreas


subject: UMLS:C1170381

subject_name: Lugols Strong Iodine

object_name: thyrotoxicosis


subject: UMLS:C1170381

object_name: Graves disease


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: osteoporosis


subject: CHEBI:16347

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:16347

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:16347

object_name: Osteoporosis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:25167947

object_name: hepatitis C


subject: DRUGBANK:DB09106

subject_name: hetastarch

object_name: blood coagulation disease


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: morbid obesity


subject: CHEBI:18332

subject_name: Levothyroxine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: pleural neoplasm


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:D07V79Q44T

object_name: castration-resistant prostate carcinoma


subject: UMLS:C1566164


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Glomerular vascular disorder


subject: UNII:1C6V77QF41

object_name: Glomerulopathy


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Epilepsy, unspecified, intractable


subject: CHEBI:34741

subject_name: Equol

object_name: acne


subject: CHEBI:91464

object_name: rectum adenocarcinoma


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Malignant neoplasm of female breast


subject: CHEBI:39548

object_name: Estrogen receptor positive tumor


subject: CHEBI:16830

subject_name: Methylamine

object_name: Post-Operative Pain


subject: CHEBI:16830

object_name: opioid use


subject: CHEBI:16830

object_name: Spine Injuries and Disorders


subject: CHEBI:34840

subject_name: methyl methacrylate


subject: CHEBI:34840


subject: CHEBI:34840


subject: UMLS:C0069477

subject_name: Tilarginine


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Symptomatic irreversible pulpitis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C1365494

subject_name: artichoke extract

object_name: Dyslipidemia


subject: MESH:C056164

subject_name: fenugreek seed meal


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Refractory Lung Small Cell Carcinoma


subject: CHEBI:231614

object_name: Grade II Neuroendocrine Carcinoma


subject: CHEBI:231614

object_name: Neuroendocrine tumor grade 1


subject: CHEBI:231614

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:231614

object_name: Small cell lung cancer metastatic


subject: CHEBI:231614

object_name: Grade III Neuroendocrine Carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079

object_name: large cell neuroendocrine carcinoma


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: Metastatic neuroendocrine carcinoma


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Esophageal adenocarcinoma stage IV


subject: CHEBI:233362

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:136044

subject_name: Fimasartan

object_name: inherited lipid metabolism disorder


subject: CHEBI:136044


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: essential hypertension


subject: CHEBI:82977

subject_name: Daclatasvir

object_name: Cirrhosis


subject: CHEBI:82977

object_name: liver cirrhosis


subject: UNII:3412470A0V

subject_name: melflufen

object_name: Relapsed/refractory multiple myeloma


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide


subject: CHEBI:85662

subject_name: Lixisenatide

object_name: acute coronary syndrome


subject: UMLS:C2604519


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Increased circulating androgen concentration


subject: CHEBI:2922

subject_name: Auranofin

object_name: giardiasis


subject: UNII:QX45B99R3J

subject_name: Mavacamten

object_name: myocardial ischemia


subject: UNII:QX45B99R3J

object_name: coronary atherosclerosis


subject: CHEBI:4909

subject_name: Etodolac

object_name: Ankle Sprains


subject: CHEBI:6456

subject_name: Lidocaine


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: juvenile dermatomyositis


subject: UNII:7D0YB67S97

object_name: myositis


subject: UNII:7D0YB67S97

object_name: Myositis, CTCAE 5.0


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Subconjunctival hemorrhage


subject: PUBCHEM.COMPOUND:164888952

subject_name: Nizaracianine triflutate

object_name: Injury of ureter during surgery


subject: UNII:9FB8TLK3DL

subject_name: NIZARACIANINE TRIFLUTATE


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: malignant disease


subject: CHEBI:39548

object_name: Childhood Solid Neoplasm


subject: CHEBI:39548

object_name: Adult Solid Neoplasm


subject: CHEBI:39548

object_name: Solid Neoplasm


subject: CHEBI:39548

object_name: Recurrent Hematologic Malignancy


subject: UMLS:C2981806

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2346852

subject_name: Arnebia Indigo Jade Pearl Topical Cream

object_name: anus neoplasm


subject: CHEBI:85990

subject_name: Panobinostat

object_name: acute myeloid leukemia with minimal differentiation


subject: UMLS:C1175653

object_name: adult lymphoma


subject: UMLS:C1175653

object_name: lymphoma


subject: UMLS:C1175653

object_name: pediatric lymphoma


subject: UMLS:C1175653

object_name: lymphoid leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Adverse effects


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:3286

subject_name: Cabergoline

object_name: abortion in second trimester


subject: UMLS:C3256448

subject_name: Tagetes erecta flower extract

object_name: hyperlipidemia


subject: UMLS:C3256448

object_name: hyperlipoproteinemia


subject: UMLS:C3256448

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C3256448

object_name: Serum lipids high (finding)


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: small cell carcinoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: CHEBI:6427

subject_name: Leuprolide

object_name: ovarian hyperstimulation syndrome


subject: CHEBI:135515

subject_name: Bendamustine

object_name: prostate small cell carcinoma


subject: CHEBI:135515

object_name: prostate carcinoma


subject: CHEBI:135515

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:135515

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UMLS:C2348117

subject_name: Tubulin-Binding Agent SSR97225

object_name: neoplasm


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Depression, psychotic


subject: CHEBI:31236

object_name: Severe major depression with psychotic features


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: glucose metabolism disease


subject: CHEBI:89981

subject_name: Endotoxins


subject: PUBCHEM.COMPOUND:44356648

subject_name: TNF-ALPHA


subject: PUBCHEM.COMPOUND:44356648

object_name: Inflammation


subject: PR:000000134

subject_name: tumor necrosis factor


subject: PR:000000134


subject: UMLS:C1522669

subject_name: Recombinant Tumor Necrosis Factor-Alpha


subject: UMLS:C1522669


subject: UMLS:C1456820

subject_name: Tumor Necrosis Factor-alpha


subject: UMLS:C1456820


subject: UMLS:C0592073

subject_name: Roaccutane

object_name: acne


subject: CHEBI:80270

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:52943177

object_name: heart failure


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C5706472

subject_name: Anti-GDF-15 Monoclonal Antibody AZD8853

object_name: bladder tumor


subject: UMLS:C5706472

object_name: non-small cell lung carcinoma


subject: UMLS:C5706472

object_name: colorectal cancer


subject: UMLS:C5706472

object_name: colorectal carcinoma


subject: UMLS:C5706472

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1704263

subject_name: green tea extract

object_name: Arterial Stiffness


subject: UMLS:C1704263

object_name: Dyslipidemia


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: UMLS:C4521010

subject_name: AutoSynVax Vaccine

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: UMLS:C2981857


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Disorder of wrist region


subject: CHEBI:26710

object_name: Hand Injuries and Disorders


subject: MESH:C000730795

object_name: liver cancer


subject: MESH:C000730795

object_name: liver neoplasm


subject: MESH:C000730795

object_name: Adult Liver Carcinoma


subject: MESH:C000730795

object_name: liver carcinoma


subject: UMLS:C2349000

subject_name: Human Papillomavirus Vaccine V503

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: UMLS:C5556657

subject_name: IDH1 Inhibitor KY100001

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Low back pain


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: bone disorder


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: PUBCHEM.COMPOUND:138657983


subject: PUBCHEM.COMPOUND:138657983

object_name: Advanced Lymphoma


subject: UMLS:C5555571

subject_name: STING Agonist SNX281


subject: UMLS:C5555571


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: uterine fibroid


subject: CHEBI:9667

object_name: adenomyosis


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:59224

object_name: obesity


subject: CHEBI:59224

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: PUBCHEM.COMPOUND:44151801


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C5856654

subject_name: Copper Cu 64-Tz-SarAr

object_name: pancreatic neoplasm


subject: UMLS:C5856654

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5856654

object_name: malignant pancreatic neoplasm


subject: UMLS:C5856654

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5856654

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5856654

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C5856653

subject_name: Anti-CA19-9 Antibody hu5B1/TCO Immunoconjugate


subject: UMLS:C5856653


subject: UMLS:C5856653


subject: UMLS:C5856653


subject: UMLS:C5856653


subject: UMLS:C5856653


subject: UMLS:C4725071

object_name: Childhood Solid Neoplasm


subject: UMLS:C4725071

object_name: Adult Solid Neoplasm


subject: UMLS:C4725071

object_name: Solid Neoplasm


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: perinatal necrotizing enterocolitis


subject: UNII:L500PR95QA

object_name: necrotizing enterocolitis


subject: UNII:L500PR95QA

object_name: Necrotizing Enterocolitis, AE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UNII:4A4RGA2CP2

object_name: Marburg hemorrhagic fever


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: BH4-deficient hyperphenylalaninemia A


subject: UNII:7OSV6M6T4D

subject_name: ALNUCTAMAB

object_name: EXCESS LMW-DNA


subject: UMLS:C5446703

subject_name: Alnuctamab


subject: UMLS:C0733859

subject_name: Otrivin

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C0733859

object_name: COPD, severe early onset


subject: UMLS:C0733859

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0733859

object_name: Nasal congestion


subject: CHEBI:10082

subject_name: Xylometazoline


subject: CHEBI:10082


subject: CHEBI:10082


subject: CHEBI:91435

subject_name: Linifanib

object_name: colon adenocarcinoma


subject: CHEBI:91435

object_name: rectum adenocarcinoma


subject: UMLS:C1738762

subject_name: ABT 869


subject: UMLS:C1738762


subject: PUBCHEM.COMPOUND:60123241

subject_name: beta-Sitostenone

object_name: Sleep Deprivation


subject: PUBCHEM.COMPOUND:60123241

object_name: Cognitive changes


subject: PUBCHEM.COMPOUND:60123241

object_name: Military activity


subject: PUBCHEM.COMPOUND:60123241

object_name: military combat stress reaction


subject: CHEBI:16134

subject_name: Ammonia


subject: CHEBI:16134


subject: CHEBI:16134


subject: CHEBI:16134


subject: UMLS:C0876283

subject_name: Ammonia Inhalants


subject: UMLS:C0876283


subject: UMLS:C0876283


subject: UMLS:C0876283


subject: CHEBI:90942

subject_name: Ixazomib

object_name: triple-negative breast carcinoma


subject: CHEBI:90942

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:6VN101530Y

object_name: multiple sclerosis


subject: UMLS:C0961900


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: differentiated thyroid carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UNII:Y68179SY2L

object_name: small intestinal neuroendocrine tumor G1


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:49865963

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:49865963

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:49865963

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:49865963

object_name: small intestine cancer


subject: PUBCHEM.COMPOUND:49865963

object_name: small intestine carcinoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Uric acid renal calculus


subject: CHEBI:8228

object_name: acute urate nephropathy


subject: GTOPDB:11607

subject_name: barzolvolimab

object_name: eosinophilic esophagitis


subject: GTOPDB:11607

object_name: Eosinophilic infiltration of the esophagus


subject: UNII:4B77GX0NA3

subject_name: BARZOLVOLIMAB


subject: UNII:4B77GX0NA3


subject: UMLS:C5669595

subject_name: Barzolvolimab


subject: UMLS:C5669595


subject: UMLS:C0021735

subject_name: Viraferon

object_name: adult lymphoma


subject: UMLS:C0021735

object_name: lymphoma


subject: UMLS:C0021735

object_name: pediatric lymphoma


subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C5552625


subject: UMLS:C5552625


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b


subject: UNII:G8RGG88B68


subject: UNII:G8RGG88B68


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Child Malnutrition


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:44915

subject_name: Propofol

object_name: Intravenous anesthetic agent overdose


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: small cell lung carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: lupus vulgaris


subject: CHEBI:4026

object_name: discoid lupus erythematosus


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Autoimmunity


subject: PUBCHEM.COMPOUND:3368

object_name: lupus nephritis


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: lupus erythematosus


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UNII:QQA9MLH692

object_name: EXCESS LMW-DNA


subject: UNII:QQA9MLH692

object_name: systemic sclerosis


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: MESH:C000597235


subject: PUBCHEM.COMPOUND:71306

subject_name: vapreotide

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:71306

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:71306

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:71306


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: UMLS:C0072994


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib

object_name: Sclerodermoid chronic graft-versus-host disease


subject: UMLS:C0678100

subject_name: dinitrophenyl

object_name: melanoma


subject: CHEBI:53018

subject_name: 2,4-dinitrophenyl group


subject: CHEBI:42017


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: Intravenous Drug Abuse


subject: PR:000022493


subject: CHEBI:55340

subject_name: morphine hydrochloride

object_name: Thoracic Diseases


subject: CHEBI:17303

subject_name: Morphine


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: pain agnosia


subject: PUBCHEM.COMPOUND:9971980

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:9971980


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:32250


subject: CHEBI:32250


subject: CHEBI:75722

subject_name: Tramadol


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: thyroid tumor


subject: GTOPDB:9592

object_name: thyroid cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:66919

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:66919

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Thrombus


subject: CHEBI:38545

object_name: Postthrombotic Syndrome


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: alcohol sensitivity


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Metastatic Lesion


subject: UNII:6XC1PAD3KF

object_name: small cell lung carcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C1873773

subject_name: Ice Pharmaceutical

object_name: large B-cell lymphoma


subject: UMLS:C1873773

object_name: high grade B-cell lymphoma


subject: UMLS:C1873773

object_name: grade 3B follicular lymphoma


subject: MESH:D007053

subject_name: Ice


subject: MESH:D007053


subject: MESH:D007053


subject: CHEBI:6809

subject_name: Metamfetamine


subject: CHEBI:6809


subject: CHEBI:6809


subject: PR:000005366

subject_name: cocaine esterase


subject: PR:000005366


subject: PR:000005366


subject: PR:000002309


subject: PR:000002309


subject: PR:000002309


subject: UMLS:C3189457

subject_name: Betamethasone Dipropionate Cream

object_name: psoriasis vulgaris


subject: UMLS:C5854292

subject_name: Modified Banxia Xiexin Decoction

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel

object_name: HIV-1 infection


subject: UMLS:C0733770


subject: GTOPDB:4942

subject_name: GM-CSF


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: MESH:C585822

object_name: non-Hodgkin lymphoma


subject: MESH:C585822

object_name: nonpapillary renal cell carcinoma


subject: MESH:C585822

object_name: clear cell renal carcinoma


subject: MESH:C585822

object_name: renal cell adenocarcinoma


subject: MESH:C585822

object_name: renal cell carcinoma


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: heart valve disorder


subject: CHEBI:192614

object_name: Valvular Heart Disease, CTCAE


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:6801

subject_name: Metformin

object_name: gonadal disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Upper Respiratory Infection, CTCAE


subject: CHEBI:89324

object_name: Kawasaki Disease Symptom


subject: CHEBI:89324

object_name: Rheumatic Fever Symptom


subject: CHEBI:89324

object_name: Symptom


subject: CHEBI:89324

object_name: Acute asthma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:33353

subject_name: technetium atom

object_name: cervical polyp


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: poisoning


subject: CHEBI:31355

subject_name: Carboplatin

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: malaria


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: CHEBI:6801


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:8805

subject_name: Repaglinide


subject: UMLS:C3827119

subject_name: Recombinant Human Adenovirus Type 5 H101

object_name: pancreatic neoplasm


subject: UMLS:C3827119

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3827119

object_name: malignant pancreatic neoplasm


subject: CHEBI:16958

subject_name: beta-Alanine

object_name: Overweight or obesity


subject: CHEBI:16958

object_name: hyperglycemia


subject: CHEBI:16958

object_name: Hyperglycemia, CTCAE


subject: CHEBI:16958

object_name: Glucose in blood specimen above reference range


subject: CHEBI:16958

object_name: Prediabetes


subject: UMLS:C0000392

subject_name: beta-alanine


subject: UMLS:C0000392


subject: UMLS:C0000392


subject: UMLS:C0000392


subject: UMLS:C0000392


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Thyroid Intra-Operative Injury, CTCAE


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: cerebral infarction


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: EGFR-TKI Resistant Mutation


subject: PUBCHEM.COMPOUND:135423438

object_name: EGFR gene mutation


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:91400

subject_name: Afatinib


subject: CHEBI:4975

subject_name: Famotidine

object_name: Burn scar


subject: CHEBI:4975

object_name: Itching scar


subject: CHEBI:4975

object_name: Traumatic Wound


subject: CHEBI:4975

object_name: Injury


subject: CHEBI:4975

object_name: Wounds and Injuries


subject: CHEBI:2469

subject_name: Adefovir

object_name: Brain Stem Glioblastoma


subject: CHEBI:2469

object_name: glioma susceptibility 1


subject: UMLS:C5575704

subject_name: Gene Therapy [APC]


subject: UMLS:C5575704


subject: CHEBI:74947

subject_name: Thalidomide

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Coronary graft stenosis


subject: UMLS:C3871731

subject_name: LumaSon KIT

object_name: Hydrocephalus in infants


subject: UMLS:C3871731

object_name: Acquired hydrocephalus


subject: UMLS:C4278128

subject_name: subetta

object_name: type 1 diabetes mellitus


subject: CHEBI:487869

subject_name: clavulanate

object_name: sinusitis


subject: CHEBI:487869

object_name: Sinusitis, CTCAE


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:31355

subject_name: Carboplatin

object_name: survival time


subject: UMLS:C0770259

subject_name: Dextrose 5% and Water

object_name: Hypernatremia


subject: UMLS:C0770259

object_name: Hypernatremia, CTCAE


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Marinesco-Sjogren syndrome


subject: CHEBI:145371

object_name: Microsatellite Stable


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: bile duct carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:80581

subject_name: Morphine glucuronide

object_name: Post-Operative Pain


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Peripheral nerve disorder associated with repair of hernia


subject: UNII:31M3WLJ3KG

subject_name: Belvarafenib

object_name: Solid Neoplasm


subject: UNII:S1Z7Y5G56T

subject_name: CAMONSERTIB


subject: PUBCHEM.COMPOUND:146624881

subject_name: DIVARASIB


subject: UNII:E6S21PVT91


subject: UNII:1WPE73O1WV

subject_name: PRALSETINIB


subject: CHEMBL.COMPOUND:CHEMBL4582651

subject_name: Pralsetinib


subject: UMLS:C2826229


subject: CHEBI:73803

subject_name: Ala-Asp

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: CHEBI:27666

subject_name: Dactinomycin


subject: UMLS:C1630418

subject_name: AD Substance


subject: CHEBI:16836

subject_name: P-Nitrophenol


subject: CHEBI:27798

subject_name: nitrobenzene


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C5854583

subject_name: Anti-CEA/Anti-CD3 Bispecific Antibody BA1202

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:63632

subject_name: Topotecan

object_name: rectal neoplasm


subject: MESH:C588274

subject_name: PROSTVAC

object_name: prostate neoplasm


subject: UMLS:C3245083

subject_name: Electrolytic iron

object_name: Iron deficiency


subject: UMLS:C3245083

object_name: iron deficiency anemia


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: kidney failure


subject: UMLS:C1136845


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: UMLS:C1707048

subject_name: broccoli sprout extract

object_name: lung cancer


subject: UMLS:C1707048

object_name: lung neoplasm


subject: UMLS:C1707048

object_name: lung carcinoma


subject: UMLS:C1521807

object_name: Adult Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C1521807

object_name: adult brainstem glioma


subject: UMLS:C1521807

object_name: adult central nervous system germ cell tumor


subject: UMLS:C1521807

object_name: adult choroid plexus neoplasm


subject: UMLS:C1521807

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C1521807

object_name: adult meningeal hemangiopericytoma


subject: UMLS:C1521807

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C1521807

object_name: Adult Grade I Meningioma


subject: UMLS:C1521807

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C1521807

object_name: adult anaplastic ependymoma


subject: UMLS:C1521807

object_name: Adult Grade III Meningioma


subject: UMLS:C1521807

object_name: Adult Myxopapillary Ependymoma


subject: UMLS:C1521807

object_name: Adult Grade II Meningioma


subject: UMLS:C1521807

object_name: Adult Pilocytic Astrocytoma


subject: UMLS:C1521807

object_name: Adult Diffuse Astrocytoma


subject: UMLS:C1521807

object_name: meningeal melanocytoma


subject: UMLS:C1521807

object_name: meningeal melanocytoma, adult


subject: UMLS:C1521807

object_name: Adult Craniopharyngioma


subject: UMLS:C1521807

object_name: adult oligodendroglioma


subject: UMLS:C1521807

object_name: adult embryonal tumor with multilayered rosettes, c19mc-altered


subject: UMLS:C1521807

object_name: adult medulloblastoma


subject: UMLS:C1521807

object_name: Adult Subependymoma


subject: UMLS:C1521807

object_name: adult pineoblastoma


subject: UMLS:C1521807

object_name: Adult Mixed Glioma


subject: UMLS:C1521807

object_name: adult glioblastoma


subject: UMLS:C1521807

object_name: Adult Pineocytoma


subject: UMLS:C1521807

object_name: Adult Gliosarcoma


subject: UMLS:C1521807

object_name: Adult Ependymoma


subject: CHEBI:33380

subject_name: thulium atom

object_name: hereditary hyperbilirubinemia


subject: CHEBI:33380

object_name: hyperbilirubinemia


subject: CHEBI:33380

object_name: Prolonged neonatal jaundice


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PR:000002105


subject: PUBCHEM.COMPOUND:23725028

subject_name: Stanate (TN)


subject: PUBCHEM.COMPOUND:23725028


subject: CHEBI:174615

object_name: Wolman disease


subject: CHEBI:174615

object_name: juvenile neuronal ceroid lipofuscinosis


subject: CHEBI:174615

object_name: neuronal ceroid lipofuscinosis 3


subject: CHEBI:174615

object_name: Sandhoff disease


subject: CHEBI:174615

object_name: Gaucher disease


subject: CHEBI:174615

object_name: Tay-Sachs disease


subject: CHEBI:174615

object_name: Niemann-Pick disease


subject: CHEBI:174615

object_name: metachromatic leukodystrophy


subject: CHEBI:174615

object_name: metachromatic leukodystrophy, juvenile form


subject: CHEBI:174615

object_name: X-linked cerebral adrenoleukodystrophy


subject: CHEBI:174615

object_name: GM1 gangliosidosis


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442

object_name: Krabbe disease


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442

object_name: adrenoleukodystrophy


subject: UMLS:C0003442


subject: UMLS:C0003442


subject: UMLS:C0003442

object_name: fucosidosis


subject: CHEBI:8863

subject_name: Riluzole

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:8863

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:8863

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:8863

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:8863

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:229764

subject_name: Selinexor

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: CHEBI:229764

object_name: Triple hit lymphoma


subject: MESH:C000726164

object_name: acute lymphoblastic leukemia


subject: MESH:C000726164

object_name: acute biphenotypic leukemia


subject: MESH:C000726164

object_name: mixed phenotype acute leukemia


subject: MESH:C000726164

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C2604746

object_name: hyperlipoproteinemia type V


subject: UMLS:C5425888

subject_name: Inhaled iloprost


subject: UMLS:C5425888

object_name: Hypoxemic Respiratory Failure


subject: UMLS:C5425888

object_name: acute respiratory distress syndrome


subject: UMLS:C0592117

subject_name: Slow Sodium

object_name: hypertension


subject: UMLS:C0592117

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Refractory Leukemia


subject: UMLS:C1709429


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Prevention problem


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: plasma cell myeloma


subject: CHEBI:90863

subject_name: Sonidegib


subject: UMLS:C0106006

object_name: Glucose metabolism disorders (incl diabetes mellitus)


subject: UMLS:C0106006

object_name: Malnutrition (calorie)


subject: MESH:C483503

subject_name: neurexan

object_name: insomnia


subject: MESH:C483503

object_name: Insomnia, CTCAE 3.0


subject: MESH:C483503

object_name: Insomnia, CTCAE 5.0


subject: MESH:C483503

object_name: Stress Fracture


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: liver cirrhosis


subject: PUBCHEM.COMPOUND:11332179

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:11332179

object_name: alcohol dependence


subject: UMLS:C5667021

subject_name: Anti-FLT3/CD3 Bispecific Antibody CLN-049

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:23431961

subject_name: Sodium citrate

object_name: Corneal epithelial staining pattern


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:38909

subject_name: trisodium borate


subject: CHEBI:131366

subject_name: borax


subject: CHEBI:75227

subject_name: sodium metaborate


subject: CHEBI:33118

subject_name: Boric acid


subject: DRUGBANK:DB19167

subject_name: Poloxamine 1304


subject: UMLS:C5940949

subject_name: Tetronic 1304


subject: CHEBI:8988

object_name: ATM Gene Mutation


subject: CHEBI:8988

object_name: PALB2 Gene Mutation


subject: CHEBI:8988

object_name: BRCA1 gene mutation


subject: CHEBI:8988

object_name: BRCA2 gene mutation


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: GTOPDB:10370

subject_name: namilumab

object_name: Axial Spondyloarthritis


subject: UNII:MED485W763


subject: UMLS:C3273714


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Carcinoma of urinary bladder, invasive


subject: UMLS:C3827082


subject: CHEBI:41001

subject_name: Benzoylecgonine


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PUBCHEM.COMPOUND:8230

subject_name: Argipressin

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:8230

object_name: traumatic brain injury


subject: UMLS:C1527128

subject_name: Recombinant Vasopressin


subject: UMLS:C1527128


subject: UMLS:C0003779

subject_name: argipressin


subject: UMLS:C0003779


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:53477739


subject: UNII:C825F38B80

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5447751

subject_name: SHP2 Inhibitor BBP-398


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: Severe Sepsis


subject: UNII:C9H2L21V7U

object_name: septic shock


subject: GTOPDB:12989

subject_name: toripalimab

object_name: uterine cervix neoplasm


subject: GTOPDB:12989

object_name: cervical polyp


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: cervical cancer


subject: CHEBI:135918

object_name: cervical carcinoma


subject: CHEBI:135918


subject: CHEBI:135918


subject: UMLS:C5417807

subject_name: Liposomal Bcl-2 Antisense Oligonucleotide BP1002

object_name: Refractory acute myeloid leukemia


subject: UMLS:C5417807

object_name: Relapsing acute myeloid leukemia


subject: UNII:43EP6XV33E

subject_name: Delpazolid

object_name: Infection


subject: UNII:43EP6XV33E

object_name: infectious disease


subject: UMLS:C4049933

subject_name: Anesthesia substance

object_name: disorder of throat


subject: UMLS:C1306788

subject_name: Decongestant brand of oxymetazoline


subject: UMLS:C1306789

subject_name: Decongestant brand of pseudoephedrine


subject: UMLS:C0282374

subject_name: Decongestants


subject: CHEBI:7862

subject_name: Oxymetazoline


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:40279

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:40279

object_name: myelodysplastic syndrome with excess blasts-1


subject: CHEBI:40279

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:40279

object_name: T-cell lymphoma recurrent


subject: CHEBI:40279

object_name: acute leukemia


subject: CHEBI:40279

object_name: acute biphenotypic leukemia


subject: CHEBI:40279

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:40279

object_name: myeloid leukemia


subject: CHEBI:40279

object_name: marginal zone lymphoma


subject: CHEBI:40279

object_name: MALT lymphoma


subject: CHEBI:40279

object_name: myelofibrosis


subject: CHEBI:40279

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:40279

object_name: Adult Burkitt Lymphoma


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: UMLS:C4733517

object_name: liver carcinoma


subject: CHEBI:7575

subject_name: Nimodipine

object_name: alcohol abuse


subject: CHEBI:7575

object_name: alcohol dependence


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: carotid stenosis


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C3536908

object_name: metabolic syndrome X


subject: UMLS:C3536908

object_name: Insulin resistance


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: nicotine dependence


subject: PR:000008833

subject_name: 5-hydroxytryptamine receptor 3A

object_name: Chemotherapy-induced nausea and vomiting


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: lip and oral cavity carcinoma


subject: UNII:L500PR95QA

object_name: oral cavity cancer


subject: UNII:L500PR95QA

object_name: Neck Carcinoma


subject: UNII:L500PR95QA

object_name: head and neck neoplasm


subject: UNII:L500PR95QA

object_name: head and neck cancer


subject: UNII:L500PR95QA

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:32599


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Neoplasm of uncertain or unknown behavior of prostate


subject: CHEBI:71940

object_name: grade III prostatic intraepithelial neoplasia


subject: CHEBI:71940

object_name: benign neoplasm of prostate


subject: CHEBI:5109

subject_name: Fluocinonide

object_name: breast carcinoma


subject: CHEBI:10127

subject_name: Zonisamide

object_name: Dyskinesia


subject: CHEBI:10127

object_name: Parkinsonism


subject: CHEBI:9168

object_name: neurofibroma


subject: CHEBI:456215

subject_name: adenosine 5'-monophosphate(2-)

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:456215


subject: CHEBI:456215

object_name: pervasive developmental disorder


subject: CHEBI:456215

object_name: autism


subject: CHEBI:456215

object_name: autism spectrum disorder


subject: CHEBI:28931


subject: CHEBI:28931


subject: CHEBI:28931


subject: CHEBI:28931


subject: CHEBI:28931


subject: PUBCHEM.COMPOUND:53481006

subject_name: Adenosine 2'-phosphate


subject: PUBCHEM.COMPOUND:53481006


subject: PUBCHEM.COMPOUND:53481006


subject: PUBCHEM.COMPOUND:53481006


subject: PUBCHEM.COMPOUND:53481006


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:16335


subject: CHEBI:40050

subject_name: Amprenavir


subject: CHEBI:40050


subject: CHEBI:40050


subject: CHEBI:40050


subject: CHEBI:40050


subject: UMLS:C4084937

subject_name: Antimicrobial Peptide


subject: UMLS:C4084937


subject: UMLS:C4084937


subject: UMLS:C4084937


subject: UMLS:C4084937


subject: UMLS:C4285220

subject_name: Absorbable Modified Polymer Hemostatic Powder


subject: UMLS:C4285220


subject: UMLS:C4285220


subject: UMLS:C4285220


subject: UMLS:C4285220


subject: PUBCHEM.COMPOUND:188025


subject: PUBCHEM.COMPOUND:188025


subject: PUBCHEM.COMPOUND:188025


subject: CHEBI:228596

subject_name: MPH


subject: CHEBI:228596


subject: CHEBI:228596


subject: PR:000002069


subject: PR:000002069


subject: PR:000002069


subject: CHEBI:9555

subject_name: Tioguanine

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:9555

object_name: non-Hodgkin lymphoma


subject: CHEBI:9555

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:9555

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5390917

subject_name: Lyumjev

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5390917

object_name: type 1 diabetes mellitus


subject: DRUGBANK:DB17908

object_name: Stargardt disease


subject: CHEBI:30742

subject_name: macrogol

object_name: Dysbiosis


subject: UMLS:C5245075

subject_name: sea buckthorn oil

object_name: arteriosclerosis disorder


subject: UMLS:C5245075

object_name: atherosclerosis


subject: UMLS:C5245075

object_name: type 2 diabetes mellitus


subject: CHEBI:136042

subject_name: Teneligliptin

object_name: diabetes mellitus


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: pancreatic neuroendocrine neoplasm


subject: DRUGBANK:DB17475

object_name: Neuroendocrine tumor of pancreas


subject: DRUGBANK:DB17475

object_name: lung neuroendocrine neoplasm


subject: DRUGBANK:DB17475

object_name: digestive system neuroendocrine neoplasm


subject: DRUGBANK:DB17475

object_name: Malignant Solid Neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:6520

subject_name: Lomustine

object_name: Adult Central Nervous System Neoplasm


subject: CHEBI:6520

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:6520

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:6520

object_name: Spinal Neoplasm


subject: CHEBI:6520

object_name: spinal cancer


subject: UMLS:C0919079


subject: CHEBI:72564


subject: CHEBI:6538

subject_name: Loratadine

object_name: Heat illness


subject: CHEBI:6538

object_name: Heat Stress Disorders


subject: CHEBI:6538

object_name: Thermal injury


subject: CHEBI:6538

object_name: Abnormal sudomotor regulation


subject: CHEBI:291342

subject_name: Desloratadine


subject: CHEBI:291342


subject: CHEBI:291342


subject: CHEBI:291342


subject: CHEBI:31859

subject_name: Modafinil

object_name: Primary Insomnia


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Torticollis


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UMLS:C2241157

subject_name: Theophylline ER

object_name: Depressed mood


subject: UMLS:C2241157

object_name: Cancer patients and suicide and depression


subject: UMLS:C2241157

object_name: Depressed - symptom


subject: UMLS:C2241157

object_name: Depression, CTCAE


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Complicated grief disorder


subject: CHEBI:36791

object_name: Bereavement, life event (finding)


subject: CHEBI:36791

object_name: Loss, Grief, and Bereavement


subject: CHEBI:36791

object_name: Encounter due to bereavement


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: GTOPDB:8002

subject_name: bavituximab

object_name: prostate carcinoma


subject: GTOPDB:8002

object_name: prostate cancer


subject: GTOPDB:8002

object_name: prostate neoplasm


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: UMLS:C1707382


subject: CHEBI:8249

subject_name: Piroxicam

object_name: hypertension


subject: CHEBI:8249

object_name: Hypertension, CTCAE


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine

object_name: Crohn disease


subject: UMLS:C5667107

subject_name: BTK Inhibitor GB5121

object_name: primary central nervous system lymphoma


subject: UNII:E329HG23ZT

object_name: type 2 diabetes mellitus


subject: UMLS:C5555480

subject_name: Prusogliptin


subject: UNII:LPU25F15UQ

subject_name: Azeliragon

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: malnutrition


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C2346492

object_name: malignant neoplasm of breast stage I


subject: UMLS:C2346492

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C2346492

object_name: Carcinoma breast stage I


subject: UMLS:C2346492

object_name: Breast cancer stage II


subject: UMLS:C2346492

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C2346492

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C2346492

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:57694

object_name: Coronary artery disease progression


subject: CHEBI:16243

subject_name: Quercetin


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:18319735

object_name: metabolic syndrome X


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: scleroderma


subject: UNII:7XL5ISS668

object_name: systemic sclerosis


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:4629

subject_name: diosgenin

object_name: Androgen excess


subject: CHEBI:184381

subject_name: Bacitracin

object_name: Infection of breast implant


subject: CHEBI:474053

subject_name: Cefazolin


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: preeclampsia postpartum


subject: CHEBI:5855

object_name: severe pre-eclampsia


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6413

subject_name: Letrozole

object_name: Primary infertility


subject: CHEBI:6413

object_name: Secondary infertility


subject: PUBCHEM.COMPOUND:56998

object_name: RNA Virus Infections


subject: PUBCHEM.COMPOUND:56998

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:56998

object_name: respiratory system disorder


subject: PUBCHEM.COMPOUND:56998

object_name: viral disease


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722543


subject: UMLS:C4722543


subject: UMLS:C4722543


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: UMLS:C4722544


subject: UMLS:C4722544


subject: UMLS:C4722544


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Injection site irritation


subject: UMLS:C1521807

object_name: Stage IB Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: stage IB cervical cancer


subject: UMLS:C1521807

object_name: Stage IB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage IA Cervical Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage IA Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: stage IA cervical cancer


subject: UMLS:C1521807

object_name: stage III cervical cancer


subject: UMLS:C1521807

object_name: Stage III Cervical Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage III Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage IIB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Cervical carcinoma stage IIB


subject: UMLS:C1521807

object_name: Stage IIB Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: Cervical carcinoma stage IIA


subject: UMLS:C1521807

object_name: Stage IIA Cervical Cancer AJCC v6


subject: UMLS:C1521807

object_name: Stage IIA Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage IIA Cervical Cancer AJCC v7


subject: UMLS:C1521807

object_name: Stage IVA Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Cervical carcinoma stage IVA


subject: UMLS:C1521807

object_name: Cervical carcinoma stage IVB


subject: UMLS:C1521807

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UMLS:C1521807

object_name: Stage IVB Cervical Cancer AJCC v8


subject: UMLS:C1521807

object_name: Stage I Endometrial Carcinoma


subject: UMLS:C1521807

object_name: Endometrial cancer stage II


subject: UMLS:C1521807

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C1521807

object_name: Endometrial cancer stage III


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: Well male adult


subject: UMLS:C0078129


subject: UMLS:C2077029

subject_name: inhaled budesonide

object_name: Coronavinae infectious disease


subject: GTOPDB:8414

subject_name: trebananib

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: GTOPDB:8414

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: GTOPDB:8414

object_name: adult acute myeloid leukemia with del(5q)


subject: GTOPDB:8414

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: GTOPDB:8414

object_name: recurrent adult acute myeloid leukemia


subject: GTOPDB:8414

object_name: Untreated Adult Acute Myeloid Leukemia


subject: GTOPDB:8414

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: GTOPDB:8414

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: GTOPDB:8414

object_name: Adult Acute Myelomonocytic Leukemia


subject: GTOPDB:8414

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: GTOPDB:8414

object_name: Adult Pure Erythroid Leukemia


subject: GTOPDB:8414

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: GTOPDB:8414

object_name: adult acute monocytic leukemia


subject: GTOPDB:8414

object_name: Adult Acute Monoblastic Leukemia


subject: GTOPDB:8414

object_name: acute megakaryoblastic leukemia in adult


subject: GTOPDB:8414

object_name: Adult Erythroleukemia


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UMLS:C1541521

subject_name: AMG 386


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Microsatellite instability-high solid malignant tumor


subject: UMLS:C4331912


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:187888

subject_name: Endostatins

object_name: neurofibromatosis


subject: PUBCHEM.COMPOUND:187888

object_name: NF2-related schwannomatosis


subject: PUBCHEM.COMPOUND:187888

object_name: vestibular schwannomatosis


subject: PUBCHEM.COMPOUND:187888

object_name: acoustic neuroma


subject: CHEMBL.COMPOUND:CHEMBL4297747

subject_name: ENDOSTATIN


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: CHEMBL.COMPOUND:CHEMBL4297747


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C0534628


subject: UMLS:C1705207

subject_name: Endostar


subject: UMLS:C1705207


subject: UMLS:C1705207


subject: UMLS:C1705207


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Burn injury


subject: CHEBI:10023

object_name: Thermal injury


subject: CHEBI:10023

object_name: Dysesthesia


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


subject: UNII:EP3QG127N9

subject_name: VICRIVIROC MALEATE

object_name: HIV infection


subject: UMLS:C2349127

subject_name: Vicriviroc Maleate


subject: CHEBI:50853

subject_name: quantum dot

object_name: ulcerative colitis


subject: CHEBI:50853

object_name: inflammatory bowel disease 1


subject: CHEBI:50853

object_name: inflammatory bowel disease


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:41500

object_name: obesity


subject: CHEBI:41500

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:12443252


subject: PUBCHEM.COMPOUND:12443252


subject: PUBCHEM.COMPOUND:12443252


subject: PUBCHEM.COMPOUND:12443252

object_name: Diabetes


subject: PUBCHEM.COMPOUND:12443252

object_name: diabetes mellitus


subject: CHEBI:80774

subject_name: taurursodiol


subject: CHEBI:80774


subject: CHEBI:80774


subject: CHEBI:80774


subject: CHEBI:80774


subject: CHEBI:80774


subject: CHEMBL.COMPOUND:CHEMBL2109323

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109323

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109323

object_name: malignant pancreatic neoplasm


subject: UMLS:C3273043


subject: UMLS:C3273043


subject: UMLS:C3273043


subject: UNII:23Y0B94E49

object_name: Childhood Breast Carcinoma


subject: UNII:23Y0B94E49

object_name: breast carcinoma


subject: UNII:23Y0B94E49

object_name: breast cancer


subject: UNII:23Y0B94E49

object_name: humoral hypercalcemia of malignancy


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: sickle cell disease


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UMLS:C4724780

subject_name: Vitis vinifera extract

object_name: diabetic retinopathy


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Ann Arbor Stage II Grade 2 Follicular Lymphoma


subject: UNII:4F4X42SYQ6

object_name: Ann Arbor Stage II Grade 1 Follicular Lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:91899

object_name: Nonulcer dyspepsia


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEMBL.COMPOUND:CHEMBL2108632

subject_name: PLATELETS

object_name: intracerebral hemorrhage


subject: UMLS:C0443116

subject_name: Platelets Product


subject: CHEBI:134778

subject_name: Enbucrilate

object_name: esophageal varices


subject: CHEBI:134778

object_name: esophageal varices with bleeding


subject: UNII:8V42Y78HRU

object_name: chronic hepatitis C virus infection


subject: UMLS:C3491774


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: gastric neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Refractory Endometrial Carcinoma


subject: CHEBI:2704

object_name: Refractory Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:2704

object_name: Refractory Endometrial Adenocarcinoma


subject: CHEBI:2704

object_name: Refractory Endometrial Serous Adenocarcinoma


subject: CHEBI:2704

object_name: Refractory Endometrial Clear Cell Adenocarcinoma


subject: CHEBI:2704

object_name: Refractory Endometrial Mixed Cell Adenocarcinoma


subject: CHEBI:2704

object_name: Refractory Endometrial Undifferentiated Carcinoma


subject: UMLS:C3830285

subject_name: Extended-release Onapristone


subject: UMLS:C3830285


subject: UMLS:C3830285


subject: UMLS:C3830285


subject: UMLS:C3830285


subject: UMLS:C3830285


subject: UMLS:C3830285


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:74872

subject_name: Trp-Lys


subject: CHEBI:85252

subject_name: synaptamide

object_name: adrenocortical insufficiency


subject: CHEBI:85252

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: UNII:S4M959U2IJ

subject_name: Teplizumab

object_name: psoriasis


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Akathisia


subject: CHEBI:107736

object_name: Akathisia, CTCAE


subject: CHEBI:131167

subject_name: Losmapimod

object_name: facioscapulohumeral muscular dystrophy 1


subject: UMLS:C3272847


subject: CHEBI:478164

subject_name: Cefepime

object_name: acute kidney failure


subject: CHEBI:478164

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination


subject: UMLS:C0250480


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: Refractory Lymphoma


subject: UMLS:C2608262

subject_name: Lubricant Eye Drops

object_name: Inflammation


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:1971

subject_name: ent-Abacavir

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:1971

object_name: amyotrophic lateral sclerosis


subject: CHEBI:421707

subject_name: Abacavir


subject: CHEBI:421707


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:73629

subject_name: Phe-Asp-Cys

object_name: hepatitis C


subject: CHEBI:73629

object_name: chronic hepatitis C virus infection


subject: CHEBI:38848

subject_name: perflunafene


subject: CHEBI:38848


subject: PR:000001881

subject_name: lymphocyte activation gene 3 protein


subject: PR:000001881


subject: CHEBI:36791

subject_name: Escitalopram

object_name: treatment resistant depression


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:188804

subject_name: Telapristone acetate

object_name: Breast cancer stage II


subject: CHEBI:188804

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:188804

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:188804

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:136924190

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:50217

subject_name: selegiline

object_name: mal de Debarquement


subject: CHEBI:50217

object_name: Minimal Disseminated Disease


subject: CHEBI:15365

subject_name: Aspirin

object_name: tuberous sclerosis


subject: CHEBI:15365

object_name: situs inversus


subject: CHEBI:15365

object_name: tuberous sclerosis 1


subject: CHEBI:15365

object_name: epilepsy


subject: CHEBI:15365

object_name: Mental deterioration


subject: CHEBI:15365

object_name: Skin lesion


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Biliary carcinoma


subject: UNII:D6UWM02W81

object_name: tuberculosis


subject: CHEBI:42588

subject_name: Fenretinide

object_name: breast neoplasm


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: generalized aggressive periodontitis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Childhood Breast Carcinoma


subject: UMLS:C1145201

object_name: breast carcinoma


subject: UMLS:C1145201

object_name: breast cancer


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: CHEBI:70839

subject_name: Dasatinib

object_name: diffuse large B-cell lymphoma


subject: CHEBI:70839

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:70839

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C4287708

subject_name: Androgen Receptor Antagonist SHR3680

object_name: Advanced Salivary Gland Carcinoma


subject: CHEBI:6427

subject_name: Leuprolide


subject: UMLS:C5418043

subject_name: ADC SHR-A1811


subject: UMLS:C5785765


subject: CHEBI:75998

subject_name: Trametinib

object_name: adult hepatocellular carcinoma


subject: CHEBI:75998

object_name: liver cancer


subject: CHEBI:75998

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:75998

object_name: liver neoplasm


subject: CHEBI:75998

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: advanced adult primary liver cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:62880

subject_name: Veliparib

object_name: Pancreatic carcinoma stage III


subject: CHEBI:62880

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Regional Urothelial Carcinoma of the Renal Pelvis and Ureter


subject: CHEBI:62880

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: CHEBI:62880


subject: CHEBI:62880

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:62880


subject: CHEBI:62880

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:62880

object_name: Bladder cancer stage IV


subject: CHEBI:62880

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:62880

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:62880

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Subretinal edema


subject: CHEBI:31547

object_name: Vitreomacular traction


subject: CHEBI:6931

subject_name: Midazolam

object_name: major depressive episode


subject: PUBCHEM.COMPOUND:5281052

subject_name: Kava

object_name: cancer


subject: PUBCHEM.COMPOUND:5281052

object_name: neoplasm


subject: PUBCHEM.COMPOUND:5281052

object_name: anxiety


subject: PUBCHEM.COMPOUND:5281052

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:5281052

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:5281052

object_name: Anxiety, CTCAE 5.0


subject: PUBCHEM.COMPOUND:5281052

object_name: Stress


subject: PUBCHEM.COMPOUND:5281052

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:5281052

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:5281052

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:5281052

object_name: Depression, CTCAE


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: invasive breast carcinoma


subject: UMLS:C4053601


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Ventricular hypertrophy


subject: UMLS:C1671982

object_name: coronary artery disorder


subject: UMLS:C1671982

object_name: coronary atherosclerosis


subject: MESH:C000709231

object_name: nasopharyngeal neoplasm


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: phenylketonuria


subject: CHEBI:16347

object_name: classic phenylketonuria


subject: CHEBI:40279

subject_name: Allopurinol

object_name: inflammatory bowel disease


subject: UMLS:C4331414

subject_name: timolumab

object_name: Chronic small plaque psoriasis


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1172402

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1172402

object_name: stage IV pancreatic cancer


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C0977147

subject_name: Normal human immunoglobulin 100 mg/mL solution for injection

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: CHEBI:232328

subject_name: Dordaviprone

object_name: Metastatic well-differentiated neuroendocrine tumor


subject: UMLS:C3827072


subject: CHEBI:16171

subject_name: NMN zwitterion

object_name: Cardiovascular surgery result: exercise tolerance


subject: CHEBI:16171

object_name: Frailty


subject: CHEBI:14648

subject_name: NMN(+)


subject: CHEBI:14648


subject: CHEBI:41139

subject_name: BETAINE


subject: CHEBI:41139


subject: PUBCHEM.COMPOUND:6093202

subject_name: Nicotinamide Mononucleotide


subject: PUBCHEM.COMPOUND:6093202


subject: UMLS:C5554941

subject_name: HPV L1 Virus-like Particles Vaccine NBP615

object_name: cervical cancer


subject: UMLS:C5554941

object_name: cervical carcinoma


subject: UMLS:C4721816

object_name: acute lymphoblastic leukemia


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: cardiac allograft vasculopathy


subject: UNII:C8ADC441ME

object_name: Complications of transplanted heart


subject: UNII:XM71MYX0IQ

subject_name: Rusfertide

object_name: acquired polycythemia vera


subject: CHEMBL.COMPOUND:CHEMBL4650507

subject_name: RUSFERTIDE


subject: PUBCHEM.COMPOUND:6451272

subject_name: Iron fumarate

object_name: disease


subject: PUBCHEM.COMPOUND:6451272

object_name: hemochromatosis type 4


subject: UMLS:C1577314

subject_name: iron fumarate


subject: UMLS:C1577314


subject: UMLS:C4283960

subject_name: Wu-ling-San

object_name: Hyperuricemia


subject: UMLS:C4283960

object_name: Hyperuricemia, CTCAE


subject: CHEBI:38623

subject_name: EC 1.4.3.4 (monoamine oxidase) inhibitor

object_name: Parkinson disease


subject: UMLS:C2917433

subject_name: Monoamine Oxidase Type B Inhibitor [EPC]


subject: CHEBI:72296

subject_name: Apixaban

object_name: Tako-tsubo cardiomyopathy


subject: CHEBI:4653

subject_name: Dipyridamole


subject: PUBCHEM.COMPOUND:154723996

subject_name: Heme arginate

object_name: Reperfusion Injury


subject: PUBCHEM.COMPOUND:154723996

object_name: Graft failure


subject: UNII:R1B526117P


subject: UNII:R1B526117P


subject: PUBCHEM.COMPOUND:3086464

subject_name: Normosang


subject: PUBCHEM.COMPOUND:3086464


subject: UMLS:C0132849


subject: UMLS:C0132849


subject: PUBCHEM.COMPOUND:26945

subject_name: Aqua-cem


subject: PUBCHEM.COMPOUND:26945


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: resistant hypertension


subject: CHEBI:31300

object_name: Hypertension resistant to conventional therapy


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: cardiovascular disorder


subject: CHEBI:6801

subject_name: Metformin

object_name: spinal cord injury


subject: CHEBI:193615

object_name: pancreatic adenocarcinoma


subject: CHEBI:60761

subject_name: Floxuridine


subject: UMLS:C0947603

subject_name: FUDR brand of floxuridine


subject: UMLS:C1095908

subject_name: legume preparation

object_name: Prediabetes


subject: UMLS:C5226694

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C2976285

subject_name: TAK 438

object_name: Helicobacter pylori [H. pylori] infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:35341

subject_name: steroid

object_name: Facial Paresis


subject: CHEBI:35341

object_name: Bell's palsy


subject: CHEBI:22587

subject_name: antiviral agent


subject: CHEBI:22587


subject: UMLS:C0003451

subject_name: Antiviral Agents


subject: UMLS:C0003451


subject: UMLS:C5551438

subject_name: Antiviral [EPC]


subject: UMLS:C5551438


subject: CHEBI:2453

subject_name: Acyclovir


subject: CHEBI:2453


subject: PUBCHEM.COMPOUND:152165

object_name: subarachnoid hemorrhage


subject: PUBCHEM.COMPOUND:152165

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:152165

object_name: traumatic brain injury


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:60799

subject_name: Esketamine

object_name: ovarian cancer


subject: CHEBI:60799

object_name: ovarian neoplasm


subject: CHEBI:60799

object_name: ovarian carcinoma


subject: UMLS:C0305578

subject_name: Centrum

object_name: Sensory Disorders


subject: UMLS:C0305578

object_name: Prognathism


subject: UMLS:C0305578

object_name: autosomal dominant prognathism


subject: UMLS:C0305578

object_name: Retrognathia


subject: PUBCHEM.COMPOUND:16056828


subject: PUBCHEM.COMPOUND:16056828


subject: PUBCHEM.COMPOUND:16056828


subject: PUBCHEM.COMPOUND:16056828


subject: CHEBI:27786

subject_name: Hydroxocobalamin


subject: CHEBI:27786


subject: CHEBI:27786


subject: CHEBI:27786


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C5960224

subject_name: Anti-FRalpha/Exatecan ADC LY4170156

object_name: peritoneal neoplasm


subject: UMLS:C5960224

object_name: fallopian tube neoplasm


subject: UMLS:C5960224

object_name: Neoplasm Metastasis


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Weight Change


subject: CHEBI:31236

object_name: Psychotic disorder due to a general medical condition


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: hypersomnia


subject: UMLS:C1527137

object_name: Hypersomnia, CTCAE


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:31859

subject_name: Modafinil

object_name: Dyssomnias


subject: CHEBI:31859

object_name: Sleep abnormality


subject: UNII:939U7C91AI

subject_name: Solriamfetol


subject: UNII:939U7C91AI


subject: UNII:939U7C91AI

object_name: sleep disorder


subject: UMLS:C3254633

subject_name: MT103 cpd

object_name: acute lymphoblastic leukemia


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: plexiform neurofibroma


subject: UMLS:C5237724

subject_name: Zeripatamig

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C5237724

object_name: B-cell neoplasm


subject: UMLS:C3896931

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: UNII:L1F3R18W77

subject_name: Asciminib


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage IV Cutaneous Merkel Cell Carcinoma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: stage IV Merkel cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: Recurrent Merkel Cell Carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C0751599

subject_name: Betantrone


subject: UMLS:C0751599


subject: UMLS:C0751599


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Dyspnea


subject: CHEBI:7773

object_name: Dyspnea, CTCAE


subject: CHEBI:7773

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:3638

subject_name: Chloroquine

object_name: sickle cell disease


subject: UMLS:C1832024

subject_name: fermented wheat germ extract

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5783725

subject_name: Narlumosbart

object_name: humoral hypercalcemia of malignancy


subject: CHEBI:135590

subject_name: Ambroxol

object_name: Diabetic peripheral neuropathy


subject: UNII:5X0D9H16IU

subject_name: EPRODISATE DISODIUM

object_name: abdominal obesity-metabolic syndrome


subject: UNII:5X0D9H16IU

object_name: metabolic syndrome X


subject: UNII:5X0D9H16IU

object_name: type 2 diabetes mellitus


subject: UMLS:C1880542

subject_name: Eprodisate Disodium


subject: UMLS:C1880542


subject: UMLS:C1880542


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: Recurrent Childhood Glioblastoma


subject: DRUGBANK:DB17475

object_name: Recurrent Glioblastoma


subject: MESH:C477385

subject_name: montanide ISA 51


subject: MESH:C477385


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C2987346

subject_name: SurVaxM


subject: UMLS:C2987346


subject: UMLS:C0662900

object_name: recurrent childhood acute myeloid leukemia


subject: UMLS:C0662900

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:125354

subject_name: Plerixafor


subject: CHEBI:125354


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Headache


subject: UMLS:C0013227

object_name: Headache, CTCAE


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:6121

subject_name: Ketamine

object_name: Poisoning caused by rattlesnake venom


subject: CHEBI:93775

subject_name: Amethopterin

object_name: tubal pregnancy


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C2697892

subject_name: Aerosol Sargramostim

object_name: metastatic melanoma


subject: UMLS:C2697892

object_name: Melanoma recurrent


subject: UMLS:C2697892

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C2697892

object_name: Unresectable Melanoma


subject: UMLS:C2697892

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:188025

object_name: Disruptive mood dysregulation disorder


subject: CHEBI:228596

subject_name: MPH


subject: CHEBI:6887

subject_name: Methylphenidate


subject: PR:000002069


subject: UMLS:C5555042

subject_name: Danvilostomig

object_name: nasopharyngeal carcinoma


subject: UMLS:C5555042

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C4764313

subject_name: Zoster Vaccine Recombinant, Adjuvanted

object_name: Infection following immunization


subject: UMLS:C4764313

object_name: Varicella zoster


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: Blood Loss


subject: CHEBI:16586

object_name: Coxitis


subject: CHEBI:16586

object_name: Arthritis of knee


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: CHEBI:36088


subject: CHEBI:45652

subject_name: Succinylcholine

object_name: no feeling or sensation of skin


subject: CHEBI:45652

object_name: Sensory Loss


subject: CHEBI:9939

subject_name: Vecuronium


subject: CHEBI:9939


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: Fever


subject: CHEBI:213747

subject_name: Friulimicin B

object_name: Community-Acquired Pneumonia


subject: CHEBI:213747

object_name: staphylococcal infection


subject: CHEBI:213747

object_name: Staphylococcal Skin Infections


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Chronic ulcerative colitis


subject: CHEBI:4909

subject_name: Etodolac

object_name: ovarian cancer


subject: CHEBI:4909

object_name: ovarian neoplasm


subject: CHEBI:4909

object_name: ovarian carcinoma


subject: CHEBI:4909

object_name: Stage II Ovarian Cancer AJCC v8


subject: CHEBI:4909

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:4909

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4909

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:4909

object_name: Ovarian cancer stage IV


subject: CHEBI:4909

object_name: Ovarian cancer stage III


subject: CHEBI:4909

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:4909

object_name: malignant epithelial tumor of ovary


subject: CHEBI:4909

object_name: primary peritoneal carcinoma


subject: CHEBI:4909

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:4909

object_name: peritoneal carcinoma


subject: CHEBI:4909

object_name: fallopian tube carcinoma


subject: CHEBI:4909

object_name: fallopian tube cancer


subject: CHEBI:4909

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:4909

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:4909

object_name: Stage II Fallopian Tube Cancer AJCC v8


subject: CHEBI:4909

object_name: Stage II Fallopian Tube Cancer


subject: CHEBI:4909

object_name: Stage III Fallopian Tube Cancer AJCC v6


subject: CHEBI:4909

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: CHEBI:4909

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:8499

subject_name: Propranolol

object_name: Stage II Ovarian Cancer AJCC v8


subject: CHEBI:8499

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: UMLS:C2713028

subject_name: ABI 009

object_name: Perivascular epithelioid tumor, malignant


subject: UMLS:C2713028

object_name: tuberous sclerosis 2


subject: UMLS:C2713028

object_name: situs inversus


subject: UMLS:C2713028

object_name: tuberous sclerosis 1


subject: CHEBI:15365

subject_name: Aspirin

object_name: endometriosis


subject: UMLS:C0338265

subject_name: Cisplatin/Gemcitabine

object_name: non-small cell lung carcinoma


subject: UMLS:C0796493

subject_name: Docetaxel/Gemcitabine


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: kidney failure


subject: CHEBI:8356

subject_name: Pramipexole


subject: UMLS:C2981799

subject_name: edotreotide lutetium LU-177

object_name: Somatostatin Receptor Positive


subject: UMLS:C2981799

object_name: central nervous system cancer


subject: UMLS:C2981799

object_name: Childhood Solid Neoplasm


subject: UMLS:C2981799

object_name: Adult Solid Neoplasm


subject: UMLS:C2981799

object_name: Solid Neoplasm


subject: UMLS:C2981799

object_name: Ewing sarcoma


subject: UMLS:C2981799

object_name: peripheral primitive neuroectodermal tumor


subject: UMLS:C2981799

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C2981799

object_name: rhabdomyosarcoma


subject: UMLS:C2981799

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C2981799

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C2981799

object_name: adult lymphoma


subject: UMLS:C2981799

object_name: lymphoma


subject: UMLS:C2981799

object_name: pediatric lymphoma


subject: UMLS:C2981799

object_name: Plexosarcoma


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: glioma


subject: CHEBI:90001

subject_name: cystathionine ketimine


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:145374

subject_name: Enasidenib

object_name: myeloproliferative neoplasm


subject: CHEBI:145374

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:145374

object_name: IDH gene mutation


subject: CHEBI:145374

object_name: Liquid Tumor


subject: CHEBI:145374

object_name: leukemia


subject: CHEBI:91408

subject_name: Fedratinib


subject: CHEBI:91408


subject: CHEBI:91408


subject: CHEBI:91408

object_name: IDH2 gene mutation


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:78140854


subject: UMLS:C0042210

subject_name: Vaccines

object_name: acquired immunodeficiency


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: diabetic retinopathy


subject: PUBCHEM.COMPOUND:11227182

subject_name: Lipitor

object_name: myopathy